RightEye Enters Into Agreement With MIT to Research Ocular Biomarker 'Signature' for Lyme Disease
April 25, 2022 11:15 ET
|
RightEye LLC
BETHESDA, Md., April 25, 2022 (GLOBE NEWSWIRE) -- RightEye, the world's leading eye-tracking biomarker company, has signed a research collaboration agreement with the Massachusetts Institute of...
Evidence of Manipulated Lyme Disease Diagnostics Presented to Suffolk County, NY Health Commissioner
March 11, 2022 08:00 ET
|
TruthCures
GREAT RIVER, N.Y., March 11, 2022 (GLOBE NEWSWIRE) -- Nonprofit grassroots organization TruthCures, Inc. held a virtual meeting with Suffolk County, NY Health Commissioner Gregson Pigott, MD, MPH,...
Bay Area Lyme Foundation Funds $8M in Tick-borne Disease Research During the Pandemic
January 25, 2022 12:17 ET
|
Bay Area Lyme Foundation
PORTOLA VALLEY, Calif., Jan. 25, 2022 (GLOBE NEWSWIRE) -- Bay Area Lyme Foundation, a leading sponsor of Lyme disease research in the US, today announced that the organization has raised more than...
Lyme Disease Advocacy Organization Meets With FDA
October 26, 2021 10:00 ET
|
TruthCures
BOSTON, Oct. 26, 2021 (GLOBE NEWSWIRE) -- Nonprofit grassroots organization TruthCures met with Food & Drug Administration (FDA) officials Monday, Oct. 18, 2021 to discuss issues related to...
Hyperbaric Oxygen Therapy Market size worth $ 4.79 Billion, Globally, by 2028 at 6.24% CAGR: Verified Market Research®
September 23, 2021 10:00 ET
|
Verified Market Research
Jersey City, New Jersey, Sept. 23, 2021 (GLOBE NEWSWIRE) -- Verified Market Research recently published a report, “Hyperbaric Oxygen Therapy Market” By Product Type (Monoplace HBOT, Topical HBOT,...
Tarsus Pharmaceuticals, Inc. Initiates Phase 1 Callisto Trial of TP-05, a Novel, Oral, Non-Vaccine Therapeutic for the Prevention of Lyme Disease
June 16, 2021 16:05 ET
|
Tarsus Pharmaceuticals, Inc
More than 30 million Americans at risk for Lyme disease exposure, which can result in severe neurological and other debilitating symptoms First participants dosed in single ascending dose and...
Tarsus Pharmaceuticals, Inc. Announces FDA Acceptance of Investigational New Drug Application for TP-05 for Lyme Disease Prevention
May 04, 2021 16:05 ET
|
Tarsus Pharmaceuticals, Inc
Novel candidate in development aims to be first approved non-vaccine therapeutic for Lyme disease prevention Allows initiation of Phase 1 study to evaluate safety, pharmacokinetics, and dosing More...
Traditional Naturopath Shares Inspiring Journey to Healing from Addiction, Chronic Illness in Debut Memoir
January 19, 2021 07:00 ET
|
Balboa Press
GIBSON, La., Jan. 19, 2021 (GLOBE NEWSWIRE) -- Author and traditional naturopath Michelle L. Potter has published her uplifting memoir that invites readers to share in Potter’s persistence and...
Lui Franciosi of Franciosi Consulting Launches YouTube Channel
December 22, 2020 19:37 ET
|
Franciosi Consulting Ltd.
VANCOUVER, British Columbia, Dec. 22, 2020 (GLOBE NEWSWIRE) -- Lui Franciosi is proud to announce the launch of his new YouTube channel. As a pharmacologist and former executive in the...
Lui Franciosi Launches New Business Website
December 22, 2020 19:07 ET
|
Franciosi Consulting Ltd.
VANCOUVER, British Columbia, Dec. 22, 2020 (GLOBE NEWSWIRE) -- Lui Franciosi is proud to announce the launch of a new business website for his company, Franciosi Consulting Ltd. Franciosi Consulting...